Purification and Characterization of the Small Subunit of Phage T4 Terminase, gp16, Required for DNA Packaging*

(Received for publication, August 7, 1996, and in revised form, November 13, 1996)

Hsingchi Lin Dagger §, Martha N. Simon par and Lindsay W. Black Dagger §**

From the Dagger  Department of Biochemistry and the Molecular and Cell Biology Graduate Program, University of Maryland Medical School, Baltimore, Maryland 21201-1503 and the  Biology Department, Brookhaven National Laboratory, Upton, New York 11973

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Phage T4 terminase is an enzyme that binds to the portal protein of proheads and cuts and packages concatemeric DNA. The T4 terminase is composed of two subunits, gene products (gp) 16 and 17. The role of the small subunit, gp16, in T4 DNA packaging is not well characterized. We developed a new purification procedure to obtain large quantities of purified gp16 from an overexpression vector. The pure protein is found in two molecular weight forms, due to specific C-terminal truncation, displays in vitro packaging activity, and binds but does not hydrolyze ATP. gp16 forms specific oligomers, rings, and side-by-side double rings, as judged by native polyacrylamide gel electrophoresis and scanning transmission electron microscopy measurements. The single ring contains about eight monomers, and the rings have a diameter of about 8 nm with a central hole of about 2 nm. A DNA-binding helix-turn-helix motif close to the N terminus of gp16 is predicted. The oligomers do not bind to DNA, but following denaturation and renaturation in the presence of DNA, binding can be demonstrated by gel shift and filter binding assays. gp16 binds to double-stranded DNA but not single-stranded DNA, and appears to bind preferentially to a gene 16-containing DNA sequence.


INTRODUCTION

Packaging of DNA into most dsDNA1 bacteriophage heads requires an enzyme, terminase, which interacts with the portal vertex of the prohead and concatemeric DNA to form a packaging machine. Terminases in most of the phages contain two subunits. The large subunit generally has DNA-dependent ATPase and endonuclease activities, whereas the DNA-binding specificity resides in the small subunit (cf. Ref. 1). lambda  terminase specifically binds and cuts at a unique cos site to leave 12-base 5' protruding complementary ends at both termini (2, 3). For phages P1 or P22, the terminases bind and cut specifically near an initiation packaging (pac) site and then generate nonspecific ends, which result from processive headful packaging (4, 5). Although it was first established in phage T4 that the mature DNA ends result from headful packaging, in the case of T4 the mechanism of DNA end formation in packaging is less well defined (6). In fact, the phage T4 terminase displays many of the features of other phage terminases, including the small (gp16) and large (gp17) subunit structure (1, 7). Our genetic studies implicate gp16, the small subunit of T4 terminase, in amplifying a gene 17-gene 19 fragment. This is achieved by recombination following alignment of two homologous 24-base pair segments within gene 16 and gene 19 in T4 Hp17 (amplification) mutants. A synapsis model was proposed to correlate this novel activity with the known role of gene 16 in initiation of DNA packaging and in controlling activity of gp17, the terminase large subunit. This amplification suggests DNA binding by gp16 whose sequence specificity remains to be assessed (8, 9).

ATP hydrolysis is required for phage in vitro DNA packaging (1, 10). ATP not only provides an energy source for DNA translocation into the prohead, but also acts as an allosteric effector to control terminase holoenzyme specificity (11). lambda  terminase has two ATP binding sites, where the high affinity site is located in the large subunit, and the low affinity site exists in the small subunit in which a weak ATPase activity was detected (12-14). It is possible that ATP binding to the terminase small subunit may serve mainly as an allosteric effector rather than in energy transduction. Thus in the Bacillus subtilis phage SPP1, the small subunit binds but does not hydrolyze ATP (15). In T4, the large subunit showed DNA-dependent ATPase activity (7), whereas gp16 did not. This is consistent with our present findings; weak ATP binding to gp16 is observed, but not ATP hydrolysis.

Many overexpressed small terminase subunits form high molecular weight species. Overexpressed lambda  gpNu1 was found mainly in insoluble aggregates, raising difficulties for purification as well as for the study of DNA binding. This obstacle has been overcome by a well established solubilizing method, followed by a subsequent renaturation step (16). On the other hand, overexpressed T4 gp16 (Mr = 18,387; Ref. 17) is quite soluble, although it chromatographs as a high molecular weight complex whose structural properties were not characterized (7).

In this study, a new overexpression vector for production of gp16 at a higher level was constructed and a novel purification scheme was developed to obtain higher yields of pure active gp16. This report characterizes the DNA packaging activity, ATP affinity, and DNA binding properties of gp16, as well as the structure of the monomeric protein and of two specific oligomeric assemblies that it forms in vivo and in vitro.


EXPERIMENTAL PROCEDURES

Plasmid Construction and Protein Overexpression

An XhoI-EcoRI fragment containing gene 16 and its ribosome binding site (RBS) as well as the T4 late promoter for genes 16 and 17 (7, 17) was cut from plasmid pR16, and inserted into a pET12a vector containing a phi 10 T7 promoter, to make pL16 (Fig. 1). HMS174 (DE3) was transformed with pL16 and induced at A600 = 0.4 by adding 0.4 mM IPTG at 37 °C for 4 h as described by Studier et al. (18).


Fig. 1. gp16 overexpression plasmid, pL16, and the purification scheme. A, the XhoI-EcoRI fragment from pR16 (7), which contains gene 16 and the overlapping gene 17 with their ribosome binding sites inserted into pET12a. B, summary of the gp16 purification scheme following gp16 expression from pL16.
[View Larger Version of this Image (24K GIF file)]


Purification Scheme

IPTG induced HMS174 (DE3) bacteria containing pL16 from 2 liters of Luria Broth were collected by centrifugation at 4,225 × g for 10 min and resuspended in buffer A (20 mM Tris-HCl (pH 7.0), 1 mM EDTA, 0.5 mM DTT, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)). The suspension was then disrupted in a French press at a pressure of 20,000 lb. After centrifuging down the cell debris at 26,890 × g for 30 min, 5% (final concentration) streptomycin sulfate was added to the 30-ml supernatant. The supernatant was stirred for 20 min at 4 °C and centrifuged again at 26,890 × g for 30 min. Solid ammonium sulfate was slowly added to the streptomycin supernatant to reach 50% final concentration at 4 °C. After sitting on ice for 1 h, the insoluble material was collected by centrifuging at 26,890 × g for 1 h and was resuspended in 15 ml of buffer B (20 mM Tris-HCl (pH 7.0), 0.5 mM DTT, and 0.1 mM PMSF). Solid urea was added to reach a final concentration of 6 M after overnight dialysis against buffer B. The urea-denatured sample was loaded into a 10-ml Bio-Rad ceramic hydroxyapatite column, which was equilibrated with buffer C (buffer B + 6 M urea). After extensively washing with buffer C, a 0-10 mM sodium phosphate (pH 7.0) gradient in buffer C was developed. A Bio-Rad high Q column (5-ml cartridge) was equilibrated with buffer Q (50 mM Tris-HCl (pH 7.5), 0.5 mM DTT, 0.1 mM ATP, 1 mM EDTA, 5 mM MgCl2, and 0.1 mM PMSF). The hydroxyapatite peak fractions were freed from urea gradually by dialysis against buffer Q containing, successively, 3, 1.5, 0.75, and 0 M urea. The renatured protein was loaded onto the High Q column, and a 0.10-1 M NaCl gradient was applied. The fractions containing gp16, as judged by SDS-PAGE, were collected and rechromatographed on the High Q column to remove high molecular weight contaminants. Except for the room temperature hydroxyapatite column, the remainder of the purification was performed at 4 °C on a Bio-Rad Econo System.

Preparation of Anti-gp16 Antiserum and Immunoprecipitation

100 µg of gp16 was eluted from the gel according to Hager and Burgess (19). 20-30 µg of the eluted gp16 in phosphate-buffered saline was emulsified with an equal volume of Freund's complete adjuvant and injected into the rabbit subcutaneously. 20 µg of eluted gp16 in Freund's incomplete adjuvant was injected subcutaneously 3 weeks later. A subsequent booster, using 10 µg of gp16, was given similarly to the first one. Four days later, the antiserum was obtained and was able to interact with gp16 as judged by Western blotting. The preimmune serum was harvested prior to the first antigen injection from the same rabbit. 35S-Labeled late protein lysates from T4 wild type and mutants grown in a non-suppressor-containing strain were obtained according to Vanderslice and Yegian (20), except the labeling time was from 10-35 min after the first infection. 10 µCi/ml [35S]methionine (850 Ci/mmol) was added to the overexpression strain after a 10-min induction. A labeled gp16-containing bacterial lysate was harvested 50 min after the addition of the isotope at 37 °C. Labeled bacterial extracts were prepared immediately after centrifugation by boiling in SDS-polyacrylamide gel electrophoresis running buffer, and 15,000 cpm from each lysate was used to do immunoprecipitation with anti-gp16 antiserum according to the procedure of McNicol et al. (21).

ATP-photoaffinity Labeling and ATPase Assay

20 µl of gp16 in 50 mM Tris-HCl (pH 7.4), 10% glycerol, 6 mM MgCl2, 5 mM DTT, 5 µM gp16, and 0.5 µM [alpha -32P]ATP (800 Ci/mmol) was incubated at 37 °C for 60 s. Then it was placed on parafilm resting on an aluminum block on ice and irradiated with a General Electric G15T8 15-watt germicidal UV lamp at a distance of 8 cm for 20 min. 1 µl of 50 mM ATP was added to stop the reaction. After the addition of 10 µg of gp16 as carrier protein, 200 µl of 20% trichloroacetic acid was added and a precipitate was allowed to form on ice for 1 h. After spinning at 23,500 × g for 1 h, the pellet was washed with 1 ml of 20% trichloroacetic acid followed by acetone. Then it was subjected to SDS-PAGE, dried, and autoradiographed (22). ATPase assays were carried out by chromatography on polyethyleneimine-cellulose, followed by autoradiography according to Debreceni et al. (23).

STEM Microscopy

Analysis of oligomers of gp16 was performed at Brookhaven National Laboratory using the STEM facility. Freeze-dried specimens for mass analysis were prepared by the wet film technique (24). Briefly, samples in solution were deposited on thin carbon film, which had tobacco mosaic virus (TMV) as an internal control previously deposited on them. The samples were extensively washed with 20 mM ammonium acetate before being freeze-dried overnight. Stained specimens were prepared similarly except that the final wash was stain, which in this case was 2% methylamine vanadate (Nanovan, Nanoprobes, Inc., Stony Brook, NY), and the samples were air-dried.

Mass analysis of unstained freeze-dried specimens is possible because the number of scattered electrons collected by the annular detectors in the dark field mode is directly proportional to the mass thickness. An automated computer program (Automass) was developed by J. Wall to analyze the digital STEM data. By subtracting the background of the thin carbon supporting film, using an appropriate calibration (either determined from the control TMV present, or using the microscope calibration), the sum of the scattered electrons over the area of an individual particle gives its molecular weight. The Automass program selects TMV segments and particles to measure which fit a model (models) whose parameters have been chosen. Two different models were used to select the larger oligomer forms (see Table II).

Table II.

STEM measurement for the mass of gp16 oligomers


Oligomers Average mass Copy numbers

kDa
1. Oligomer 141.89  ± 46.98 8.11  ± 2.68
2. Dimeric oligomer a. 327.49  ± 67.21a 18.7  ± 3.84
b. 349.78  ± 46.78a 20.0  ± 2.67

a  Analysis of the STEM measurement by two different calculation parameters is shown.

DNA Probes and Gel Shift Binding Assay

A 24-base ssDNA oligonucleotide sequence (5'-GAAGCTCATGATGCTCGTCAGAAG-3') was synthesized (Biopolymer Lab located at University of Maryland at Baltimore Medical School). 10 pmol of DNA was labeled by phosphorylation with bacteriophage T4 polynucleotide kinase (25). The radiolabeled fragment was purified by Ultrafree-MC filter units, 5,000 nominal molecular weight limitation low binding-regenerated cellulose membrane (Millipore), spun at 6,500 rpm (microcentrifuge) for 1 h. 100 µl of Tris-EDTA (TE) buffer was added, and the oligonucleotide was spun for another 1 h to wash free of radioactive mononucleotide. The probe was resuspended in 30 µl of TE (pH 8.0).

A 215-base pair PCR product, made from pL16 with primer 22 (5' GAATGCGACAGTATTCATGG 3') and primer 4 (5' AGATTTTATCCAATGAATTCCATCT 3'), which corresponds to the 3' end of gene 16 (8), was isolated from 4% FMC Nusieve GTG agarose run in 1 × Tris-acetate-EDTA (TAE) buffer using a Qiaex gel extraction kit from Qiagen Co. The DNA fragment was labeled by T4 polynucleotide kinase (25) and was purified as the above except using Ultrafree-MC filter units, 10,000 nominal molecular weight limitation low binding-regenerated cellulose membrane.The labeled DNAs (8 × 10-8 µm ssDNA; 2.5 × 10-7 µm 215-base pair dsDNA fragment) were mixed with 2.7 × 10-3 µm denatured gp16 in 100 µl (final volume) of buffer Q with 2 M urea and renatured by gradually dialyzing away the urea from Q buffer containing successive urea concentrations of 1, 0.5, 0.25, 0.125, 0.00125, and 0 M. The renatured gp16 with or without the addition of anti-gp16 antiserum or preimmune serum was run on an 8% native polyacrylamide gel in 1 × TAE in the presence of ATP and Mg2+. The gel was dried and subjected to autoradiography.

DNA Filter Binding Assay

Plasmids pL16 and pET12a were radioactively labeled by nick translation (Amersham Corp.). Membrane filters (HATF) from Millipore were soaked in soaking buffer (50 mM Tris-HCl (pH 7.5), 0.5 mM DTT, 3 mM ATP, and 1.5 mM MgCl2) for 30 min. gp16 was concentrated by 5% trichloroacetic acid precipitation on ice and washed twice with acetone. The dried pellet was redissolved to 10 mg/ml in M urea in Q buffer. Aliquots of the 6 M urea-dissolved protein were pipetted into a series of microcentrifuge tubes. The protein was then gradually renatured by adding aliquots (sequential additions of the original volume) of the Q buffer to dilute the urea. When the protein was suspended in 2 M urea, 5 fmol of DNA probe (3000-5000 cpm) was added to each reaction tube in the final volume of 20 µl. By adding serial amounts of Q buffer, the protein and probe were renatured gradually by diluting the urea concentration to 1, 0.5, and 0.25 M at room temperature. The samples were then allowed to sit at room temperature overnight, and 1 ml of Q buffer was added the next day, mixed, and the mixture slowly filtered through the membrane at a speed of 2 ml/min on a Millipore filtration manifold. The membranes were washed once with 1 ml of 50 mM NaCl in 50 mM Tris-HCl (pH 7.5) and 2.5 mM EDTA. The membranes were air-dried and subjected to scintillation counting.

Protein and DNA Gel Analysis

A 12.5% SDS-polyacrylamide gel was used for the separation of the gp16 monomer, and an 8% native polyacrylamide gel was used for the DNA binding (band shift) measurements and for characterization of the oligomeric complexes. Polyacrylamide gels were run by standard methods (25). Electroblotting of SDS-PAGE for N-terminal sequencing was according to Bio-Rad, and N-terminal sequencing was done by the Macromolecular Resources Lab at Colorado State University. C-terminal sequencing of the purified gp16 (Q2, Table I) and of the two proteins separated by SDS-PAGE and blotted onto Teflon supports (26) was kindly performed by Dr. Jerome Bailey, Hewlett-Packard Co. Mass spectrometry was carried out on fraction Q2 at the Hewlett-Packard Co., Palo Alto, Calif. Protein concentration was determined by the Bradford assay (Bio-Rad).

Table I.

Purification of terminase subunit gp16

Table shows the measurement of the specific packaging activities in fractions shown in Fig. 1B.
Fractiona Protein amounts Total activity Specific activity Yields Purification

mg unitsb units/µg % -fold
1. Crude extract 984 8.0  × 1011 8.1  × 105 100 1
2. Ammonium sulfate 42 8.8  × 1010 2.1  × 106 11 2.6
3. Hydroxyapatite 20.4 (0) (0) (0) (0)
4. Renaturation 20.4 3.9  × 1011 1.9  × 107 48.8 23.5
5. High Q (Q1) 13.2 3.3  × 1011 2.5  × 107 41.2 30.9
6. High Q (Q2) 9.8 3.0  × 1011 3.1  × 107 37.5 38.3

a  Fractions are as described in Fig. 1B.
b  Unit is a plaque forming unit assayed as defined under "Materials and methods".

Other Materials and Methods

The in vitro T4 DNA packaging assay was according to Black (27) using gene 16amN87-amN67 rII deletion mutant-infected bacterial extracts containing ~2 × 109 proheads.


RESULTS

New Purification Procedures

pL16 has three ATG and RBS sites (Fig. 1): one in the NdeI site 5' to the gene 16 coding region, a second at the beginning of gene 16, and a third within gene 16 which initiates translation of gene 17 at the five-codon, out-of-frame overlapping region between genes 16 and 17. The first 105 base pairs of gene 17 remain in the pL16 plasmid. A truncated peptide is expected from the first ATG, since there are two downstream stop codons before the second gene 16 ATG site. Therefore, the overexpressed gp16 is expected to be synthesized only from the RBS and ATG site for gene 16 found in the phage T4 DNA sequences. Optimal synthesis of gp16 from the expression vector was assessed by Western blotting using an antiserum prepared against gp16 (data not shown). The overexpression level could reach about 5-10% of the total protein (Fig. 2), which is much higher than the previous lambda pL promoter driven overexpression plasmid, pR16 (7). Following a new purification procedure of six steps (Fig. 1), concentrated gp16 was obtained with about a 40-fold increase in specific DNA packaging activity (Table I). In the final High Q column, a 0.10 to 1.0 M NaCl gradient was applied and the protein profile was followed by SDS-PAGE. The correspondence of the protein (as measured by A280), gp16 (SDS-PAGE Coomassie Brilliant Blue R-250 stained for protein), and activity profiles with an in vitro DNA packaging assay is given in Fig. 3. The new purification scheme, summarized in Table I, gave us about 40% yield of active purified protein, 1% of the total protein, and more than ~95% purity was achieved.


Fig. 2. The protein profiles on SDS-polyacrylamide gel of steps in the purification. Lane 1, protein size markers. Lane 2, the cell lysate without IPTG induction. The induced lysate is shown in lane 3. gp16 was overexpressed in the range of 5-10% of the total protein. The streptomycin sulfate supernatant, which was used in subsequent purification steps, is shown in lane 4. Lane 5, the ammonium sulfate precipitate. Hydroxyapatite, Q1, and Q2 fractions (Table I) are shown in lanes 6-8, respectively.
[View Larger Version of this Image (86K GIF file)]



Fig. 3. Assessment of the purity of gp16 in the final chromatography step and synthesis of two molecular weight forms of gp16. A, correspondence of the packaging activity with gp16 by chromatography. The packaging activity profile ( ... ) coincides with the gp16 protein profile (B) and the protein profile (----, A280) in the final High Q column. - - -, the conductivity profile. B,gp16 is found in two molecular weight forms. The eluted gp16 protein appears as a doublet upon SDS-PAGE (see "Results"). C, phage T4 infection results in synthesis of predominantly the truncated gp16 species. The major band of 35S-labeled protein immunoprecipitated either from pL16 overexpression (lane 3) or from T4-infected bacteria (lane 4) appears in the truncated gp16 position when compared to the doublet of purified gp16 (lane 7) on the Coomassie Brilliant Blue R-250 stained gel. Lanes 1 and 2, T4 and pL16 lysates; lane 5, 16amN87amN67 immunoprecipitate; Lane 6, the Coomassie Brilliant Blue R-250 stained gel of lane 4, the mixture of 35S-labeled immunoprecipitate and purified gp16. Lanes 1-5, autoradiography; lanes 6 and 7, protein staining.
[View Larger Version of this Image (29K GIF file)]


The purified gp16 appeared as a closely migrating doublet band upon SDS-polyacrylamide gel electrophoresis (Fig. 3B). 35S-labeled immunoprecipitates from pL16 and T4-infected bacteria also appear as a doublet in about the same proportions, i.e. the major gp16 component immunoprecipitated is the lower band (Fig. 3C). Both proteins yielded the predicted gp16 N-terminal sequence following blotting and microsequencing, MEGLDINK, strongly suggesting that both are gene 16 products. Mass spectrometry of the purified gp16 (Q2 fraction) that gave rise to the doublet showed a mixture of two components with masses of 18,406 and 17,513 Da, as compared to a DNA sequence (17) calculated molecular mass of 18,387 Da. The major C-terminal group was arginine, and the minor end group was the expected aspartic acid, which corresponded to the end groups found in the major lower band, and the minor upper band, respectively, following analysis of the electroblotted proteins (26). Loss of nine amino acids from the C-terminal end of the full-length protein would leave an arginine C terminus and yield a protein with predicted molecular mass of 17,448 Da. Therefore, a specific C-terminal truncation of a majority of the polypeptide chains apparently yields the two components detected after the purification (see "Discussion").

DNA Packaging Activity

The activity of purified gp16 was measured by an in vitro DNA packaging assay. Trace activity (~2 × 103 plaque-forming units/ml) was present even in the absence of gp16, since the small subunit is partially dispensable for the packaging of mature DNA (7). The DNA packaging activity of purified gp16 appeared to reach a plateau value at ~0.3 µg (0.33 µM) (Fig. 4). The activity decreased slightly thereafter, possibly due to the presence of high salt in the sample, or because the inactive oligomer is favored over the formation of the gp16-gp17 holoenzyme. The purified gp16 contains no endonuclease activity as measured (data not shown). The purified protein is highly active, since a half-maximal yield of phage is reached at a concentration of the purified gp16 of about 5.5 × 10-2 µM (0.05 µg). However, the enzymatic activity measured in the lower concentration range is not linear with respect to the amount of protein added. Probably, multiple copies of gp16 are required to form an active packaging gp16-gp17 (terminase) complex, which occurs below the 0.01 µg (1.1 × 10-2 µM) level and contributes to a threshold stage (Fig. 4, inset). When gp16 and gp17 are co-expressed, the gp17 and gp16 are found to be associated during purification, although the association appears to be weak (7).


Fig. 4. The enzymatic activity of gp16 at high and low concentrations. The activity of the purified protein reaches a plateau value at ~0.3 µg (0.33 µM). This follows a lag phase in appearance of activity in the low concentration range as shown in the inset.
[View Larger Version of this Image (14K GIF file)]


ATP-photoaffinity Labeling and ATPase Activity

ATP was UV-cross-linked to gp16 (22), and the labeling was prevented by the presence of 50 (and 500) µM non-radioactive ATP (Fig. 5, A and B). Without UV irradiation, ATP was not able to cross-link to gp16 (data not shown). We observed that the lower gp16 band (the major form) bound ATP less well than the upper band. Unexpectedly, a ~50-kDa band appeared in the protein-stained gel as well as the autoradiogram. Since the band also appeared in the UV-irradiated sample containing protein without the addition of any ATP, but was dependent upon UV irradiation, it could be due to cross-linking of protein monomers to form multimers via tyrosine residues, which are in proximity in the gp16 oligomer. ATPase activity was also measured in the presence and absence of dsDNA and of 1% Sarkosyl to dissociate the oligomers; however, no ATP hydrolysis was detected even following overnight incubation with 10 µg of gp16 (data not shown). Of course, a gp16-associated ATPase activity could appear when the protein is assembled with gp17 and proheads.


Fig. 5. ATP-photoaffinity labeling of gp16. A, the Coomassie Brilliant Blue R-250 stained gel, which shows the position of the gp16 doublet following SDS-polyacrylamide gel electrophoresis; B, the autoradiogram of A. Lane 1, the protein size markers. Lanes 2 and 3 represent 10 and 20 min of UV incubation time, respectively. Lanes 4 and 5 show the results of the UV incubation carried out in the presence of 50 and 500 µM nonradioactive ATP.
[View Larger Version of this Image (36K GIF file)]


The Structure of the gp16 Oligomers

The purified gp16 fractions were run on an 8% native polyacrylamide gel. gp16 migrated as two sharp high molecular weight complexes toward the top of the gel, C1 and C2, with little or no detectable gp16 monomer (Fig. 6). The oligomers reformed from M urea, and were stable in 1 M NaCl, although Sarkosyl treatment released some monomer (Fig. 6, lane 9). The molecular weight of the lower major band was judged from the polyacrylamide migration compared to standards to be in the mass range of 150-200 kDa. This measurement is consistent with the STEM measurement of the complexes (Table II).


Fig. 6. gp16 forms stable oligomers (C1 and C2) as judged by native polyacrylamide gel electrophoresis. Lanes 1 and 2, protein size markers. Fractions 15-20 (Q2) are shown in lanes 3-7, respectively. Lane 8, gp16 renatured from 6 M urea. Lane 9, partial dissociation of the oligomer into monomeric form (M) in the presence of Sarkosyl.
[View Larger Version of this Image (57K GIF file)]


Fraction 19 from the 8% native acrylamide gel was used to prepare specimens for the STEM. Masses were determined on unstained, freeze-dried specimens, such as shown in Fig. 7A. The summary of the mass measurements is shown in Table II. A histogram of the mass measurements (Fig. 8) shows that the mass distribution over 680 particles is bimodal, suggesting that the sample contained at least two populations of particles. One appeared quite round, possibly with a hole in the center, indicated by single-headed arrows in Fig. 7. The other was more rectangular and is indicated by double-headed arrows. The mass determination suggests that the round particles are an oligomer of approximately eight copies of gp16, whereas the other form appears to be approximately a dimer of that.


Fig. 7. STEM micrographs of gp16 oligomers. A, a dark field micrograph of freeze-dried gp16. The molecular weight of the oligomers can be determined from these digital data. The long structure in the upper left corner is tobacco mosaic virus (TMV) used as an internal control. One component of this population is indicated by single-headed arrows. A second component is indicated by double-headed arrows. The full width of the micrograph is 0.512 µm. B, a bright field micrograph of gp16 stained with methylamine vanadate. The single- and double-headed arrows indicate the same components as in A. The full width of the micrograph is 0.128 µm. C, the same as B, except the full width of the micrograph is 0.064 µm.
[View Larger Version of this Image (124K GIF file)]



Fig. 8. Histogram of the mass distribution over gp16 oligomers.
[View Larger Version of this Image (17K GIF file)]


While unstained freeze-dried specimens are necessary for mass measurements, fine structural details are often blurred because of radiation damage in the electron beam. Stained specimens were prepared from the same fraction 19. The hope was to see some symmetry in the round particles to better determine their oligomeric state. Fig. 7B shows the stained specimens. The single arrows point to round particles that are indeed rings. What was surprising was the structure of the larger particles, indicated by double-headed arrows, which appear to be two joined, interlocked, or side-by-side rings. The single rings can be seen in Fig. 7C. They are rings with a diameter of approximately 8 nm and a hole of approximately 2 nm diameter. There is no obvious symmetry. In stain, both forms appear slightly irregular and variable, which is what was seen in their mass measurements.

DNA Binding Activity

Modified DNA filter binding and band shift assays using a denaturation and renaturation process demonstrated that gp16 binds to dsDNA. A 215-base pair DNA fragment corresponding to the 3' end of gene 16 was used as a probe in a modified gel band shift assay (see "Experimental Procedures"), which showed a band shift only after gp16 in the presence of the dsDNA probe underwent denaturation and renaturation, as compared to the reaction with the oligomer (Fig. 9B, lanes 2 versus 1). In addition, a minor, slower migrating band (x in Fig. 9B) always appears in the free dsDNA probe. Loop formation after denaturation and renaturation or bending could explain the appearance of this minor component and its absence in lanes 2-4 (Fig. 9B) could be explained by greater accessibility to contaminants in the purified gp16 or antisera. gp16 binding to DNA was enhanced by the presence of the gp16 antiserum, which contributed to a band supershift (Fig. 9B, lane 4) that was absent when using the preimmune serum (Fig. 9B, lane 3). In contrast, a ssDNA did not show any evidence of gp16 interaction using the same procedures (Fig. 9A), suggesting specificity for double-stranded DNA. The band shift assay is not quantitative, and use of other DNA fragments that did not correspond to gene 16 sequences also showed band shifts under these assay conditions (data not shown).


Fig. 9. Demonstration of gp16 binding to dsDNA but not ssDNA by a modified gel shift assay. A, ssDNA probe was used. Lane 1 shows the gp16 plus probe without denaturation and renaturation. gp16 with the probe following denaturation and renaturation is shown in lane 4. Besides the protein and probe, preimmune serum and anti-gp16 antiserum were added, as shown in lanes 2 and 3, respectively. Lane 5, free probe. B, dsDNA probe was used. Lane 1, gp16 plus probe without denaturation and renaturation. Lane 2, gp16 plus probe following the denaturation and renaturation. Lanes 3 and 4 represent the addition of preimmune and anti-gp16 antiserum, respectively, along with gp16 and probe obtained from the denaturation and renaturation. Lane 5, free probe. x, a minor DNA structure; open circle , gp16-DNA complex; *, anti-gp16 antibody-gp16-DNA complex.
[View Larger Version of this Image (42K GIF file)]


When quantitative DNA filter binding assays were carried out, the results supported the band shift assays in showing binding of gp16 to DNA. By this method of detection, binding also requires the denaturation and renaturation procedure. Binding to pL16 is stronger than to pET12a, suggesting preferential binding to a gene 16 sequence (Fig. 10). Under such conditions, the binding occurs only when the molar ratio of protein:probe is over 10,000 and a critical protein concentration is achieved. A comparable requirement for high molar ratios of protein to DNA to observe DNA binding has also been observed for other terminase small subunit proteins (see "Discussion").


Fig. 10. A DNA filter binding assay using purified gp16 denatured and renatured in the presence of DNA (see "Experimental Procedures"). In the presence of the indicated amounts of gp16 in the final volume of 20 µl, bindings of radioactive pL16 (bullet ) and pET12a (open circle ) were assayed.
[View Larger Version of this Image (12K GIF file)]


At its N-terminal end, gp16 contains a predicted helix-turn-helix (H-T-H) motif, similar in structure and location to the putative DNA binding motifs of gpNu1 and gp1, the small subunits of lambda  and SPP1 terminases, respectively. The gp16 sequence has the characteristic signature pivot residues of a H-T-H structure, Ser7, Gly11, and Ile17. This region of gp16 is predicted to be alpha -helical (28). In addition, 60% homology with H-T-H residues in other proteins in addition to conservative replacements at other positions are observed (Table III).

Table III.

The putative helix-turn-helix (HTH) DNA binding motif

*, gp16 amino acid identity to other HTH motif-containing proteins. Underlines indicate residues with the signature pivot A7, G11, and I/V17 spacing for the helix-turn-helix in the 22-residue motif. aa, amino acids.
Protein 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

T4 gp16 (aa 9-26)a L L D I <UNL>S</UNL> D L P <UNL>G</UNL>  I  D  G  E  E  <UNL>I</UNL>  K  V  Y
*   * *   * *      *        *           *
SPP1 phi  Gp1 (aa 26-43)a A T K A <UNL>A</UNL> I A A <UNL>G</UNL>  Y  S  K  K  S  <UNL>A</UNL>  S  T  I
 lambda GpNu1 (aa 5-22)a K K Q L <UNL>A</UNL> D I F <UNL>G</UNL>  A  S  I  R  T  <UNL>I</UNL>  Q  N  W
E. coli laca L Y D V <UNL>A</UNL> E Y A <UNL>G</UNL>  V  S  Y  Q  T  <UNL>V</UNL>  S  R  V
E. coli gala I K D V <UNL>A</UNL> R L A <UNL>G</UNL>  V  S  V  A  T  <UNL>V</UNL>  S  R  V
Mat ala K E E V <UNL>A</UNL> K K C <UNL>G</UNL>  I  T  P  L  Q  <UNL>V</UNL>  R  V  W
P22 croa N R A V <UNL>A</UNL> K A L <UNL>G</UNL>  I  S  D  A  A  <UNL>V</UNL>  S  N  W
i434croa Q T E L <UNL>A</UNL> T K A <UNL>G</UNL>  V  K  Q  Q  S  <UNL>I</UNL>  Q  L  I
 lambda cIb Q E S V <UNL>A</UNL> D K M <UNL>G</UNL>  M  G  Q  S  G  <UNL>V</UNL>  G  A  L
E. coli capb R Q E I <UNL>G</UNL> Q I V <UNL>G</UNL>  C  S  R  E  T  <UNL>V</UNL>  G  R  I
E. coli Trpb Q R E L <UNL>K</UNL> N E L <UNL>G</UNL>  A  G  I  A  T  <UNL>I</UNL>  T  R  G

a  Putative HTH motifs.
b  Crystal HTH motifs.

The DNA binding domains from lambda  and other proteins were determined by crystallography or predicted by computer homology search. Comparison of gpNu1 predicted an N-terminal DNA binding domain (29). A DNA binding motif of gp1 in phage SPP1 is well characterized, and the sequence also shows some similarities to gpNu1 (15). Therefore, all three comparable molecular weight terminase proteins contain the binding motif in the same N-terminal region, an unusual location among H-T-H proteins.


DISCUSSION

T4 terminase is an enzyme that displays DNA-dependent ATPase, DNA packaging, and endonuclease activities. The active holoenzyme did not bind to single-stranded or double-stranded DNA columns during purification, suggesting that other factors are required to activate DNA binding in vivo (7). The individual subunits display different activities. The large subunit gene apparently is associated with nonspecific endonuclease activity and is toxic to the host cells when overexpressed alone (30). Gene 16 reduced gene 17 toxicity and allowed its overexpression in a lambda pL promoter-containing plasmid (7). Possibly, gp16 modulates gp17 to produce a more specific regulated endonuclease activity following assembly into holoenzyme, as gpNu1 does with gpA in lambda  (31).

Despite minimal sequence homology, phage terminases often display similar organization of structural and functional domains. We observed that the intact gp16 binds ATP more strongly than the truncated form, which implies an effect of the truncation on the ATP interaction site. The ATP reactive site was predicted to lie in the center of other small subunits (lambda  and SPP1) (14, 15) as well as in roughly the same region of gp16, although the ATP consensus binding motif is more ambiguous in gp16 (17). Clearly, the truncated gp16 also participates in oligomer formation. The oligomerization may be due to highly hydrophobic interactions in the central portion of gp16, according to the hydropathy analysis (28), of two regions, amino acids 62-70 and amino acids 73-80, which corresponded to the oligomerization central regions of gpNu1 and gp1 of lambda  and SPP1, respectively (15, 16). In phages lambda and P22, partially overlapping out-of-frame small and large terminase genes comparable to the T4 gene structure are also found (32).

The purified gp16 protein appeared as two SDS-polyacrylamide gel electrophoresis bands with the same N-terminal sequence, but with different C-terminal ends. From mass spectrometry measurement and C-terminal analysis, the shorter, major component is specifically truncated at its C terminus by 9 amino acid residues as compared to the minor full-length protein. The most likely mechanism for the formation of the shorter gp16 is premature arrest in translation at the overlapping gene 17. The ribosome binding site (5' AGAAGG 3') for gp17 synthesis is located 1 nucleotide (nt) downstream of the short form terminal arginine codon. A -1 frameshift at this site would lead to a termination codon (UGA) immediately after the arginine codon. Although truncation by specific C-terminal proteolysis by a tryptic-type activity cannot be excluded, this seems unlikely because a serine-protease inhibitor did not prevent formation of the truncated gp16. Moreover, these two proteins are also synthesized in similar proportions during a T4 infection analyzed without incubation of the extract as determined by immunoprecipitation (Fig. 3C). The interaction domain between gp16 and gp17 has not been identified. However, in phage lambda , the C terminus of the small subunit interacts with the N terminus of the large subunit (33). It could be that in T4 synthesis of the major truncated gp16 component accounts for the weak association to gp17 during the purification of the holoenzyme if only the minor full-length gp16 binds to gp17 (7). However, the biological roles of the two gp16 proteins in vivo remain to be tested.

Our present biochemical analysis of gp16 is compatible with the genetic evidence suggesting a DNA binding role of this component of the T4 terminase (8). Most of the terminase small subunits are DNA-binding proteins as is predicted from extensive genetic analysis (GpNu1 in lambda , gp19 in T3, and gp1 in SPP1) (cf. Ref. 1). As already discussed, several small terminase subunits, including gp16, contain a predicted helix-turn-helix DNA binding motif. However, in order to show DNA binding, a large excess of each protein has generally been required in the binding reaction. In our DNA binding assay, we also used a very high molar ratio of protein:DNA (>10,000-fold), and denaturation and renaturation together with the DNA were also required to observe binding in the gel band shift and filter binding assays. A threshold concentration of protein was also required for the filter binding, comparable to that observed for the SPP1 gp1 binding (34). In the case of SPP1, other factors were not required for DNA binding. In the case of phage lambda , other DNA-binding proteins (IHF or HU) are required for binding (35). From our analysis, the gp16 oligomer does not bind DNA and the tendency of gp16 to oligomerize is very strong. We suppose that other factors are also required to observe the T4 small subunit DNA binding in vivo; however, urea denaturation allows a specific nucleoprotein complex to form in their absence.

The native polyacrylamide gel and STEM analysis shows that the gp16 oligomer, far from being a nonspecific aggregate, consists of specific ring and double ring structures. The STEM measurements show that the oligomer is an ~8-nm ring with a ~2-nm central hole, with approximately eight subunits, on average, per single ring. In fact, this is the first close look at the structure of a terminase subunit. A comparable ring-like structure also appeared in the terminase small subunit of the B. subtilis SPP1 phage, although only single rings estimated to be decamers were observed (34). A number of possible gp16 interactions might account for the formation of the ring doublet. This structure should be relatively stable, since it apparently survives native gel electrophoresis. One possibility based on a single type of gp16 self-association is that the rings are helical, and that the ring doublet is a flattened two-turn helix, i.e. the rings and double rings are actually washers and double washers, where the latter has spread out due to weak stacking. How the T4 ring structures correlate with terminase function and DNA binding are interesting questions. We speculate that gp16 forms an analogous nucleoprotein complex with the DNA. The formation of ring dimers could correspond to the postulated synapsis of two homologous DNA fragments, serving either as a packaging signal or triggering the recombination event in vivo probably in conjunction with other host or phage accessory proteins (8).

Previous studies indicating that gp16 was not only involved in DNA packaging but also in the sequence-specific in vivo recombination of two homologous sequences, which results in the formation of multiple copies of terminase gene 17 and adjacent genes (8), suggested that the T4 terminase subunit recognizes a pac-like site for preferential packaging. In this work we did observe preferential binding to gene 16-containing plasmid DNA. Deletion of the pac-like sequence in gene 16-containing plasmid constructions also resulted in substantial decreases in T4 transduction of these plasmid DNAs.2 Taken together with the DNA binding studies reported in the present study, it appears that the small terminase subunit does bind preferentially to a sequence in its structural gene. Studies are under way to determine the extent of this binding specificity and the identification of other accessory factors required for this binding in vivo.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Supported by National Institutes of Health Grant AI11676.
par    Supported by National Institutes of Health Biotechnology Research Resource Grant RR01777 and United States Department of Energy.
**   To whom correspondence should be addressed: Dept. of Biochemistry and Molecular and Cell Biology Graduate Program, University of Maryland Medical School, 108 N. Greene St., Baltimore, MD 21201-1503. Tel.: 410-706-3510; Fax: 410-706-8297; E-mail: lblack{at}umabnet.ab.umd.edu.
1    The abbreviations used are: dsDNA, double-stranded DNA; ssDNA, single-stranded DNA; gp, gene product; RBS, ribosome binding site; IPTG, isopropyl-1-thio-beta -D-galactopyranoside; STEM, scanning transmission electron microscopy; TMV, tobacco mosaic virus; H-T-H, helix-turn-helix.
2    H. Lin and L. W. Black, submitted for publication.

Acknowledgment

We thank Dr. J. Bailey, Hewlett Packard Co., Palo Alto, CA, for help in C-terminal sequencing and mass spectrometry measurement.


REFERENCES

  1. Black, L. W. (1989) Annu. Rev. Microbiol. 43, 267-292 [CrossRef][Medline] [Order article via Infotrieve]
  2. Feiss, M., and Becker, A. (1983) in Lambda II (Hendrix, R. W., Roberts, J. W., Stahl, F. W., and Weisberg, R. A., eds), pp. 305-330, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  3. Murialdo, H. (1991) Annu. Rev. Biochem. 60, 125-153 [CrossRef][Medline] [Order article via Infotrieve]
  4. Skorupski, K., Pierce, J. C., Sauer, B., and Sternberg, N. (1992) J. Mol. Biol. 223, 977-989 [Medline] [Order article via Infotrieve]
  5. Casjens, S., Sampson, L., Randall, S., Eppler, K., Wu, H., Petri, J. B., and Schmieger, H. (1992) J. Mol. Biol. 227, 1086-1099 [Medline] [Order article via Infotrieve]
  6. Streisinger, G., Emrich, J., and Stahl, M. M. (1967) Genetics 57, 292-295
  7. Rao, V. B., and Black, L. W. (1988) J. Mol. Biol. 200, 475-488 [Medline] [Order article via Infotrieve]
  8. Wu, C. H. H., Lin, H., and Black, L. W. (1995) J. Mol. Biol. 247, 523-528 [CrossRef][Medline] [Order article via Infotrieve]
  9. Black, L. W. (1995) Bioessays 17, 1025-1030 [Medline] [Order article via Infotrieve]
  10. Morita, M., Tasaka, M., and Fujisawa, H. (1993) Virology 193, 748-752 [CrossRef][Medline] [Order article via Infotrieve]
  11. Higgins, R. R., Lucko, H. J., and Becker, A. (1988) Cell 54, 765-775 [Medline] [Order article via Infotrieve]
  12. Feiss, M. (1986) Trends Genet. 2, 100-104 [CrossRef]
  13. Tomka, M. A., and Catalano, C. E. (1993) Biochemistry 32, 11992-11997 [Medline] [Order article via Infotrieve]
  14. Becker, A., and Gold, M. (1988) J. Mol. Biol. 199, 219-222 [Medline] [Order article via Infotrieve]
  15. Chai, S., Kruft, V., and Alonso, J. C. (1994) Virology 202, 930-939 [CrossRef][Medline] [Order article via Infotrieve]
  16. Parris, W., Rubinchik, S., Yang, Y.-C., and Gold, M. (1994) J. Biol. Chem. 269, 13564-13574 [Abstract/Free Full Text]
  17. Powell, D., Franklin, J., Arisaka, F., and Mosig, G. (1990) Nucleic Acids Res. 18, 4005 [Medline] [Order article via Infotrieve]
  18. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89 [Medline] [Order article via Infotrieve]
  19. Hager, D. A., and Burgess, R. R. (1980) Anal. Biochem. 109, 76-86 [Medline] [Order article via Infotrieve]
  20. Vanderslice, R. W., and Yegian, C. D. (1974) Virology 60, 265-275 [Medline] [Order article via Infotrieve]
  21. McNicol, L. A., Simon, L. D., and Black, L. W. (1977) J. Mol. Biol. 116, 261-183 [Medline] [Order article via Infotrieve]
  22. Biswas, S. B., and Kornberg, A. (1984) J. Biol. Chem. 259, 7990-7993 [Abstract/Free Full Text]
  23. Debreceni, N., Behme, M. T., and Ebisuzaki, K. (1970) Biochem. Biophys. Res. Commun 41, 115-121 [Medline] [Order article via Infotrieve]
  24. Wall, J. S., and Hainfield, J. F. (1986) Annu. Rev. Biophys. Biophys. Chem. 15, 355-376 [CrossRef][Medline] [Order article via Infotrieve]
  25. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 10.2-11.61, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  26. Bailey, J. M., Shenoy, N. R., Ronk, M., and Shively, J. E. (1992) Protein Sci. 1, 68-80 [Abstract/Free Full Text]
  27. Black, L. W. (1981) Virology 113, 336-344 [Medline] [Order article via Infotrieve]
  28. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132 [Medline] [Order article via Infotrieve]
  29. Kypr, J., and Mrazek, J. (1986) J. Mol. Biol. 191, 139-140 [CrossRef][Medline] [Order article via Infotrieve]
  30. Bhattacharyya, S. P., and Rao, V. B. (1994) Gene (Amst.) 146, 67-72 [CrossRef][Medline] [Order article via Infotrieve]
  31. Davidson, A., and Gold, M. (1987) Virology 161, 305-314 [Medline] [Order article via Infotrieve]
  32. Eppler, K., Wyckoff, E., Goates, J., Parr, R., and Casjens, S. (1991) Virology 183, 519-538 [Medline] [Order article via Infotrieve]
  33. Frackman, S., Siegele, D. A., and Feiss, M. (1985) J. Mol. Biol. 183, 225-238 [CrossRef][Medline] [Order article via Infotrieve]
  34. Chai, S., Lurz, R., and Alonso, J. C. (1995) J. Mol. Biol. 252, 386-398 [CrossRef][Medline] [Order article via Infotrieve]
  35. Shinder, G., and Gold, M. (1988) J. Virol. 62, 387-392 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.